NVAX

Novavax, Inc. NASDAQ

Healthcare ·Biotechnology ·US · novavax.com

$8.03

Mkt Cap $1.3B

52w Low $5.80 36.1% of range 52w High $11.97

50d MA $9.09 200d MA $8.20

P/E (TTM) 3.0x

EV/EBITDA 2.2x

P/B —

Debt/Equity -1.9x

ROE -344.6%

P/FCF -4.4x

RSI (14) —

ATR (14) —

Beta 2.65

50d MA $9.09

200d MA $8.20

Avg Volume 4.1M

About

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	-0.66	0.11	+116.7%	11.19	-0.4%	-9.4%	-9.7%	-15.2%	-11.6%	-10.7%	—
Nov 6, 2025	AMC	-1.08	-0.62	+42.6%	7.59	-1.6%	-2.0%	-6.3%	-2.0%	-5.1%	-7.0%	—
Aug 6, 2025	AMC	-0.07	0.62	+985.7%	7.58	+0.4%	+15.8%	+10.4%	+5.9%	+11.9%	+16.8%	—
May 8, 2025	AMC	0.71	2.93	+312.7%	6.66	-0.8%	-10.2%	-4.8%	-7.1%	-10.5%	-5.6%	—
Feb 27, 2025	AMC	-0.75	-0.51	+32.0%	7.06	+1.6%	+18.0%	+11.5%	+8.8%	+11.8%	+11.5%	—
Nov 12, 2024	AMC	-0.87	-0.76	+12.6%	8.46	-0.2%	-8.2%	-14.7%	-13.5%	-7.4%	-5.4%	—
Aug 8, 2024	AMC	1.64	0.99	-39.6%	11.68	-0.9%	-0.7%	+1.5%	+4.1%	+4.4%	+8.2%	—
May 10, 2024	AMC	-1.04	-1.05	-1.0%	8.88	+9.1%	+47.6%	+51.8%	+45.3%	+62.2%	+46.5%	—
Feb 28, 2024	AMC	-0.49	-1.44	-193.9%	4.41	-0.2%	+12.0%	+22.2%	+24.5%	+26.3%	+27.2%	—
Nov 9, 2023	AMC	-1.82	-1.26	+30.8%	6.71	-0.4%	-7.0%	-6.6%	-7.0%	-7.6%	-13.1%	—
Aug 8, 2023	AMC	-1.39	0.58	+141.7%	7.23	+2.9%	-1.5%	+6.4%	+1.8%	+0.1%	+0.1%	—
May 9, 2023	AMC	-3.38	-3.41	-0.9%	9.52	+5.1%	-5.6%	-6.6%	-11.2%	-14.8%	-19.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11.19	$11.15	-0.4%	-9.4%	-9.7%	-15.2%	-11.6%	-10.7%
Jan 20	BTIG	Maintains	Buy → Buy	—	$8.01	$8.22	+2.6%	+2.4%	+23.6%	+21.7%	+14.5%	+20.2%
Nov 18	JP Morgan	Maintains	Underweight → Underweight	—	$6.80	$6.61	-2.8%	-3.4%	-6.8%	-8.5%	-4.9%	-2.5%
Nov 10	B. Riley Securities	Maintains	Buy → Buy	—	$7.44	$7.56	+1.6%	-4.4%	+0.0%	-3.2%	-5.1%	-6.3%
Nov 4	TD Cowen	Maintains	Hold → Hold	—	$7.91	$7.69	-2.8%	-5.1%	-2.8%	-4.0%	-5.9%	-10.1%
Oct 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.46	$8.48	+0.2%	-1.2%	+0.7%	+2.8%	+0.7%	-0.9%
Aug 20	BofA Securities	Downgrade	Neutral → Underperform	—	$9.52	$8.72	-8.4%	-8.2%	-19.9%	-17.6%	-21.0%	-21.2%
Jul 22	BofA Securities	Maintains	Neutral → Neutral	—	$7.17	$7.19	+0.3%	+0.7%	+9.3%	+6.6%	+4.2%	+1.5%
May 9	JP Morgan	Maintains	Underweight → Underweight	—	$6.66	$6.61	-0.8%	-10.2%	-4.8%	-7.1%	-10.5%	-5.6%
Dec 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.07	$9.10	+0.3%	-3.3%	-2.8%	-0.6%	+0.4%	+1.8%
Nov 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.46	$8.44	-0.2%	-8.2%	-14.7%	-13.5%	-7.4%	-5.4%
Nov 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.01	$8.05	-10.7%	-6.1%	-13.8%	-19.9%	-18.8%	-13.1%
Aug 12	B. Riley Securities	Maintains	Buy → Buy	—	$11.60	$11.38	-1.9%	+2.2%	+4.8%	+5.1%	+9.0%	+11.7%
Aug 12	JP Morgan	Maintains	Underweight → Underweight	—	$11.60	$11.38	-1.9%	+2.2%	+4.8%	+5.1%	+9.0%	+11.7%
Aug 2	B. Riley Securities	Maintains	Buy → Buy	—	$12.57	$11.93	-5.1%	-6.3%	-9.5%	-8.3%	-14.8%	-7.1%
Jul 30	JP Morgan	Downgrade	Neutral → Underweight	—	$16.42	$14.44	-12.1%	-25.7%	-22.0%	-23.4%	-28.3%	-30.7%
Jun 14	BofA Securities	Maintains	Neutral → Neutral	—	$15.05	$14.32	-4.9%	-4.3%	-6.6%	-8.4%	-6.6%	-7.0%
May 23	B. Riley Securities	Maintains	Buy → Buy	—	$15.70	$16.16	+2.9%	-3.5%	-1.3%	-1.1%	-3.8%	-2.9%
May 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.88	$9.69	+9.1%	+47.6%	+51.8%	+45.3%	+62.2%	+46.5%
May 13	TD Cowen	Maintains	Hold → Hold	—	$8.88	$9.69	+9.1%	+47.6%	+51.8%	+45.3%	+62.2%	+46.5%
May 10	BofA Securities	Upgrade	Underperform → Neutral	—	$4.47	$10.02	+124.2%	+98.7%	+193.3%	+201.6%	+188.6%	+222.1%
Mar 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.94	$5.09	+3.0%	+9.1%	+11.1%	+12.8%	+13.6%	+13.6%
Feb 23	B. Riley Securities	Maintains	Buy → Buy	—	$4.88	$5.06	+3.7%	+8.4%	+12.7%	+23.4%	-9.6%	+1.2%
Aug 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.12	$7.16	+0.6%	+8.0%	+3.4%	+1.7%	+1.7%	+0.1%
Aug 9	B. Riley Securities	Upgrade	Neutral → Buy	—	$7.23	$7.44	+2.9%	-1.5%	+6.4%	+1.8%	+0.1%	+0.1%
May 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.52	$10.01	+5.1%	-5.6%	-6.6%	-11.2%	-14.8%	-19.7%
Mar 1	B. Riley Securities	Downgrade	Buy → Neutral	—	$9.26	$6.83	-26.2%	-25.9%	-25.2%	-17.0%	-21.3%	-24.7%
Feb 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$9.88	$10.02	+1.4%	-1.0%	+0.5%	+3.1%	+1.1%	+1.4%
Jan 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
Oct 14	B. Riley Securities	Maintains	Buy → Buy	—	$21.28	$21.50	+1.0%	-7.6%	-4.5%	-12.5%	-15.7%	-19.3%
Sep 22	JP Morgan	Downgrade	Neutral → Underweight	—	$25.87	$24.63	-4.8%	-13.3%	-18.8%	-27.1%	-22.5%	-24.2%
Aug 9	Cowen & Co.	Maintains	Outperform → Outperform	—	$57.25	$39.98	-30.2%	-29.6%	-27.8%	-29.5%	-27.6%	-26.1%
Jun 8	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$47.54	$52.31	+10.0%	+5.4%	-12.7%	-14.6%	-23.7%	-18.6%
May 20	BofA Securities	Maintains	Underperform → Underperform	—	$58.43	$55.71	-4.7%	-8.6%	-12.0%	-20.3%	-21.1%	-19.4%
Apr 26	B. Riley Securities	Maintains	Buy → Buy	—	$50.21	$50.00	-0.4%	-5.6%	-7.5%	-11.8%	-10.2%	+7.1%
Mar 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$86.39	$85.48	-1.1%	-6.8%	-17.0%	-19.3%	-15.7%	-8.5%
Jan 21	Cowen & Co.	Maintains	Outperform → Outperform	—	$90.36	$87.36	-3.3%	-6.3%	-12.1%	-14.6%	-12.4%	-19.3%
Dec 21	JP Morgan	Maintains	Neutral → Neutral	—	$201.95	$193.01	-4.4%	-5.4%	-9.2%	-12.2%	-21.9%	-22.8%
Jun 15	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$207.71	$200.00	-3.7%	-9.9%	-15.2%	-13.4%	-16.0%	-12.9%
May 12	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$138.18	$132.50	-4.1%	-7.5%	-12.4%	-4.7%	+1.4%	+4.6%
May 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$138.18	$132.50	-4.1%	-7.5%	-12.4%	-4.7%	+1.4%	+4.6%
May 12	JP Morgan	Downgrade	Overweight → Neutral	—	$138.18	$132.50	-4.1%	-7.5%	-12.4%	-4.7%	+1.4%	+4.6%
Mar 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$187.63	$213.51	+13.8%	+8.1%	+15.9%	+18.4%	+20.2%	+15.8%
Feb 18	B. Riley Securities	Maintains	Buy → Buy	—	$273.98	$271.99	-0.7%	-3.2%	+1.4%	-10.5%	-11.2%	-12.4%
Feb 18	B. Riley FBR	Maintains	Buy → Buy	—	$273.98	$271.99	-0.7%	-3.2%	+1.4%	-10.5%	-11.2%	-12.4%
Feb 17	B. Riley FBR	Maintains	Buy → Buy	—	$262.70	$249.20	-5.1%	+4.3%	+1.0%	+5.8%	-6.7%	-7.4%
Feb 5	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$280.92	$283.62	+1.0%	+3.3%	+13.9%	+12.4%	+6.2%	+6.2%
Feb 1	B. Riley FBR	Maintains	Buy → Buy	—	$220.94	$242.52	+9.8%	+21.4%	+19.7%	+28.6%	+27.1%	+31.3%
Feb 1	B. Riley Securities	Maintains	Buy → Buy	—	$220.94	$242.52	+9.8%	+21.4%	+19.7%	+28.6%	+27.1%	+31.3%
Jan 31	B. Riley FBR	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—

Recent Filings

8-K

Novavax Inc -- 8-K Filing

Novavax achieved $1.1 billion in 2025 revenue including $225 million from its Sanofi partnership and maintained $751 million in cash while advancing its pipeline toward 2027 clinical entries.

Feb 26

Data updated apr 26, 2026 4:13pm · Source: massive.com